Division of Bacterial Diseases (DBD)
Our Mission
The mission of the Division of Bacterial Diseases (DBD) is to prevent and control illness and death from vaccine-preventable and other respiratory bacterial diseases, in the United States and worldwide, through leadership in epidemiologic and laboratory science and policy. DBD plays a critical role in outbreak response, surveillance and epidemiologic research, laboratory diagnosis and pathogen characterization, and vaccine development, and provides scientific support for development of vaccine policy and public health guidance to control vaccine-preventable and other respiratory bacterial diseases nationally and globally.
Our Priorities
DBD is CDC’s primary unit responsible for bacterial respiratory and vaccine-preventable diseases. In addition to serving as experts in the area of bacterial respiratory and vaccine-preventable disease issues, we:
- Accelerate the development, introduction, and evaluation of vaccines against bacterial respiratory diseases such as pneumonia, meningitis, neonatal sepsis, and related syndromes in the United States and globally
- Identify, assess, and implement advanced and innovative approaches to improve and expand laboratory, statistical, and epidemiological science to support the DBD vision and advance DBD programs
- Maintain and strengthen surveillance, early detection, investigation, response, and policy development to ensure effective prevention and control of bacterial respiratory diseases such as pneumonia, meningitis, neonatal sepsis, and related syndromes in the United States and globally
- Efficiently and effectively support public health programs and research through excellence in management and operations functions
- Inform the public and scientific community about bacterial respiratory diseases such as pneumonia, meningitis, neonatal sepsis, and related syndromes in the United States and globally through effective communications and policy approaches
Our Organization
DBD is organized into an Office of the Director and two Branches (intranet only link), as follows:
- Meningitis and Vaccine Preventable Diseases
- Respiratory Diseases
DBD Organization Chart and Leadership Bios
- Leadership Bios
- Kimberley Fox, MD, MPH – Director
- Dale Rose, PhD, MSc – Deputy Director
- Mark Biagioni, MPA – Associate Director for Program Management
- Adam L. Cohen, MD, MPH – Chief, Respiratory Diseases Branch
- LeAnne Fox, MD – Chief, Meningitis and Vaccine Preventable Diseases Branch
Division Contact Information
Division Topics
- Active Bacterial Core surveillance (ABCs)
- Chlamydia pneumoniae
- Diphtheria / Corynebacterium diphtheriae
- Group A Streptococcal (GAS) Disease / group A Streptococcus
- Group B Streptococcal (GBS) Disease / group B Streptococcus
- Haemophilus influenzae disease (including Hib)
- Legionellosis / Legionella
- Legionnaires’ disease
- Pontiac fever
- Meningococcal disease /Neisseria meningitidis
- Meningitis
- Mycoplasma pneumoniae
- Pertussis / Bordetella pertussis
- Pneumococcal disease / Streptococcus pneumoniae
- Pneumonia
- Psittacosis / Chlamydia psittaci
- Tetanus / Clostridium tetani
- Unexplained Respiratory Disease Outbreaks (URDO)